Nan Fung Group Holdings Ltd: 13F holdings
CIK 17825392026Q2
| Positions | 25 |
|---|
| Reported value | $131.5m |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 25 (+1 vs prior quarter) |
|---|
| Reported value | $131.5m (+8.4%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| MAPLIGHT THERAPEUTICS INC | 971,253 | $34.8m | 26.5% |
| LBRX LB PHARMACEUTICALS INC | 630,657 | $20.5m | 15.6% |
| EVOMMUNE INC | 1,441,032 | $19.2m | 14.6% |
| CYBIN INC | 987,222 | $6.5m | 5.0% |
| INCY INCYTE CORP | 53,742 | $6.1m | 4.6% |
| RYTM RHYTHM PHARMACEUTICALS INC | 49,120 | $5.5m | 4.1% |
| ONC BEONE MEDICINES LTD | 15,722 | $4.5m | 3.4% |
| OCULIS HOLDING AG | 300,565 | $4.2m | 3.2% |
| ASCENDIS PHARMA A/S | 13,600 | $3.6m | 2.8% |
| RVMD REVOLUTION MEDICINES INC | 19,253 | $3.6m | 2.7% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1782539")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples